Gaucher disease: Variability in phenotype among siblings

被引:29
作者
Amato, D
Stachiw, T
Clarke, JTR
Rivard, GE
机构
[1] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada
[2] Univ Toronto, Fac Med, Toronto, ON, Canada
[3] Jagiellonian Univ, Sch Med, Krakow, Poland
[4] Hosp Sick Children, Toronto, ON M5G 1X8, Canada
[5] Univ Montreal, Montreal, PQ, Canada
[6] Hop St Justine, Montreal, PQ H3T 1C5, Canada
关键词
D O I
10.1023/B:BOLI.0000042983.60840.f3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although many mutations of the GBA gene have been described as causing Gaucher disease, there is generally poor correlation between genotype and phenotype, with a few exceptions. However, most previous reports of genotype-phenotype correlation have involved unrelated individuals, who, even if they share the same mutations, are not as genetically close as siblings. We have studied 24 groups (mostly pairs) of Canadian siblings with type I (non-neuronopathic) Gaucher disease. Since most Canadian provinces have adopted similar criteria for instituting enzyme replacement therapy (ERT), the age at which ERT is begun can serve as a rough surrogate for disease severity, and concordance (or lack of concordance) can be examined between siblings. In 14 of the 24 sibling families, there was sibling concordance: either both siblings were not on ERT, or both were on ERT and had begun at roughly the same age. In these families, there was also much similarity in the clinical features of the disease between siblings. In the other 10 families there was lack of sibling concordance, with only one sibling receiving ERT (or, in one family with three affected siblings, two of three on ERT). In these families, there was also much discrepancy between siblings in the clinical features (as might be expected in a setting where the guidelines for starting ERT are relatively uniform). Possible reasons for the discordances between siblings include macro-environmental and microenvironmental differences. The latter may include micro-environments at the level of the cell (e.g. lysosomal pH, alternative substrates) or at the level of the chromosome (contiguous genes, modifier genes, neutral polymorphisms in GBA).
引用
收藏
页码:659 / 669
页数:11
相关论文
共 12 条
  • [1] ARCECI RJ, 2003, BLOOD PRINCIPLES PRA, P921
  • [2] Discrepancies between genotype and phenotype in hematology: an important frontier
    Beutler, E
    [J]. BLOOD, 2001, 98 (09) : 2597 - 2602
  • [3] BEUTLER E, 2001, WILLIAMS HEMATOLOGY, P899
  • [4] Clarke JTR, 2001, CAN MED ASSOC J, V165, P595
  • [5] Exhaustive screening of the acid β-glucosidase gene, by fluorescence-assisted mismatch analysis using universal primers:: Mutation profile and genotype/phenotype correlations in Gaucher disease
    Germain, DP
    Puech, JP
    Caillaud, C
    Kahn, A
    Poenaru, L
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 63 (02) : 415 - 427
  • [6] Analysis of the β-glucocerebrosidase gene in Czech and Slovak Gaucher patients:: Mutation profile and description of six novel mutant alleles
    Hodañová, K
    Hrebícek, M
    Cervenková, M
    Mrázová, L
    Vepreková, L
    Zeman, J
    [J]. BLOOD CELLS MOLECULES AND DISEASES, 1999, 25 (18) : 287 - 298
  • [7] Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease
    Koprivica, V
    Stone, DL
    Park, JK
    Callahan, M
    Frisch, A
    Cohen, IJ
    Tayebi, N
    Sidransky, E
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 66 (06) : 1777 - 1786
  • [8] LAOSOMBAT V, 1985, J MED ASSOC THAILAND, V68, P92
  • [9] MacKenzie JJ, 1998, CAN MED ASSOC J, V159, P1273
  • [10] NILSSON O, 1985, CLIN GENET, V27, P443